Assignee
ABBISKO THERAPEUTICS CO LTD
CN·11 granted patents·14 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
25 records- 0177US10968220B2FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2017·Granted Apr 6, 2021·1 cites·5 claims
- 0265US11459339B2Biaryl derivative, preparation method thereof and pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Granted Oct 4, 2022·1 cites·13 claims
- 0363US2025382296A1Nitrogen-containing fused three ring prmt5 inhibitor, and preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0463US2025122189A1Fgfr4 inhibitor acid salt, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0562US2025320202A1Prmt5 inhibitor, preparation method therefor, and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0660US11555036B2FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Granted Jan 17, 2023·0 cites·3 claims
- 0760US2024408088A1Pyrazole derivative, and preparation method therefor and use thereof in medicineABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0858US2025179023A1Holosymmetric biphenyl derivative, and preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0955US2024360102A1Pyrimidine-4,6-diamine derivative, a preparation method therefor, and a pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1054US2024327402A1Pyrimidine or pyridine derivative, preparation method therefor, and application thereof in pharmacyABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1154US2024109885A12,3-dihydro-1h-pyrrolo[3,2-b]pyridine derivative, preparation method therefor, and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1253US2024101573A1Macrocyclic k-ras g12c inhibitor, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1352US2023303575A1Fgfr and mutation inhibitor thereof, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1450US12552811B2Immunosuppressant, and preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Granted Feb 17, 2026·0 cites·11 claims
- 1550US2022009894A11,2,3,4-tetrahydroquinoxaline derivative, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 1649US12473282B2Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Granted Nov 18, 2025·0 cites·15 claims
- 1749US2023271936A1Efgr inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1849US2024317710A1Crystalline csf-1r inhibitor acidic salt, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1945US12157755B2CD73 inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Granted Dec 3, 2024·0 cites·8 claims
- 2045US2022380342A1Biphenyl derivatives for blocking pd-1/pd-l1 interaction, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 2144US12351576B2FGFR inhibitor, preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2019·Granted Jul 8, 2025·0 cites·6 claims
- 2241US11312701B2Formylpyridine derivative having FGFR4 inhibitory activity, preparation method therefor and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Apr 26, 2022·0 cites·6 claims
- 2341US11130762B2Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacyABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Sep 28, 2021·0 cites·14 claims
- 2439US11180495B2Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Nov 23, 2021·0 cites·9 claims
- 2535US11149021B2N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereofABBISKO THERAPEUTICS CO LTD·Filed 2018·Granted Oct 19, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when ABBISKO THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →